SynthesisPloS one2021

Use of comorbidity indices in patients with any cancer, breast cancer, and human epidermal growth factor receptor-2-positive breast cancer: A systematic review.

Maribel Salas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.